AWARD
65 -- Anthrax Antitoxins for the Treatment of Inhalational Anthrax
- Notice Date
- 9/19/2013
- Notice Type
- Award Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, Office of the Secretary, Acquisitions Management, Contracts, & Grants (AMCG), Office of the Assistant Secretary for Preparedness & Response (ASPR), Department of Health and Human Services, 330 Independence Ave. SW, G640, Washington, District of Columbia, 20201, United States
- ZIP Code
- 20201
- Solicitation Number
- RFP-12-100-SOL-00026
- Point of Contact
- Jason Bell, Phone: 202-260-1457, Francine L. Hemphill, Phone: 2025731113
- E-Mail Address
-
jason.bell@hhs.gov, Francine.Hemphill@hhs.gov
(jason.bell@hhs.gov, Francine.Hemphill@hhs.gov)
- Small Business Set-Aside
- Partial Small Business
- Award Number
- HHSO100201300009I
- Award Date
- 9/19/2013
- Awardee
- CANGENE CORPORATION, 155 INNOVATION DR, WINNIPEG,, Canada
- Award Amount
- $100,000.00
- Description
- The purpose of this announcement is for the award of an Indefinite Delivery Indefinite Quantity (IDIQ) type contract to acquire, store, and distribute medical countermeasures that will mitigate injuries caused by exposure to chemical, biological threat agents, physical radiologic and nuclear exposures. The Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness & Response (ASPR) has a specific need for anthrax antitoxin products to treat individuals with symptomatic anthrax disease resulting from aerosol release of Bacillus anthracis (B. anthracis) spores.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/OOS/OASPHEP/RFP-12-100-SOL-00026/listing.html)
- Record
- SN03195875-W 20130921/130920000303-9f85909a8e362d2b8bc951cc5e077631 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |